A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty

• Status: Not yet recruiting
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to study how well the adductor canal pain catheters works after a total knee arthroplasty or replacement of the knee joint. The catheter works by using either an intermittent bolus injection to provide a large dose of medication or continuous infusion of pain medicine, ropivacaine 0.2%, compared to a single-shot adductor canal block.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Age ≥ 18 and ≤ 90 years.

• Willing to participate in the study and competent to provide informed consent.

• Willing to comply with protocol procedures.

• Has an underlying diagnosis of osteoarthritis indicated for a total knee arthroplasty.

Exclusion Criteria:

• The patient must not have taken any narcotic medications (schedule II) during the 3 months leading up to the surgery.

• The patient must not be allergic or intolerant to a medication used in the multimodal pain pathway.

• Revision knee arthroplasty.

• Uncontrolled diabetes with A1C > 8.0%.